indeed ..my systems were finding all the right ticks and then got slammed.only way out would be to exclude biotechs from universe..Could be. Looking at the recent price history, traders like myself could have been trapped and kicked out a number of times...
View attachment 112531
and earlier...
View attachment 112533
So if systems are designed in such a way to mimic trader behaviour, I can understand why they may have failed on this stock. I know I would have failed trading this stock, as I have with many other Biotech stocks in the past as I have mentioned.
Only occasionally you can be lucky to get in and ride a megatrend in these volatile stocks IMO.
Might be worth looking into why it didn't pass today. ......They might have just told them to go off and tweak XYZ and come back. Would be worth looking into.
But this is EXACTLY what happened. It didn't fail as such, they want them to run another trial for confirmatory purposes. Also, they have other products in train. IMHO it's been oversold.
They must be under water and want to go back to surface to get a breath of fresh air and get out.I saw that RBC capital has set a price target of $12. Are they pumping or is it real analysis? I have lost a bit of confidence which probably means we are at a low point for the present as emotions rule in the sharemarket.
good mornings
Any comments on MSB failures and prices collapse. It has been a roller coaster trading stock imo .
Thanks
Bought at 5 ish sold at 3.5 within a week ..now blacklisted at qldfrogYes, had enough, sold most of my shares this morning.
Just have to add that this repeated itself again and again in the last 5y, never so quickly but most often at a loss, ramp crash dilution, no thanks.i really really liked the idea but enough ..Bought at 5 ish sold at 3.5 within a week ..now blacklisted at qldfrog
I had to dump it today. Way too volatile a stock for me. Prefer money in other ventures.
In their review of Mesoblast’s interim results – released at 7pm on Friday night – the auditors say “material uncertainty exists that may cast significant doubt on the group’s ability to continue as a going concern”.
It is probably true seeing the annual report after trading halt and material transaction to be disclosed on 2nd March ..Drug development company Mesoblast could be unable to continue as a going concern if it cannot successfully raise capital before the end of this week, auditors from PwC warn.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?